Unique ID issued by UMIN | UMIN000036873 |
---|---|
Receipt number | R000042015 |
Scientific Title | Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis |
Date of disclosure of the study information | 2019/06/01 |
Last modified on | 2021/11/30 23:42:47 |
Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis
Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis
Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis
Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis
Japan |
anti-neutrophil cytoplasmic antibody associated vasculitis
Clinical immunology |
Others
NO
analysis of clinical features and prognosis
Others
To study organ involvement associated with vasculitis, outcomes of relapses, occurrences of adverse events, discontinuing of immunosuppressants, and survival rate.
To study outcomes of relapses, occurrences of adverse events, discontinuing of immunosuppressants, and survival rate, for five years.
Observational
Not applicable |
Not applicable |
Male and Female
Patients with vasculitis, whose ANCA is positive, attending Clinical Immunology and Rheumatology, Jichi Medical University Hospital.
none
400
1st name | Takamasa |
Middle name | |
Last name | Murosaki |
Jichi Medical University Hospital
Clinical Immunology and Rheumatology
3290498
3311-1, Yakushiji, Shimotsuke-city, Tochigi prefecture
0285587358
r0752tm@jichi.ac.jp
1st name | Takamasa |
Middle name | |
Last name | Murosaki |
Jichi Medical University Hospital
Clinical Immunology and Rheumatology
3290498
3311-1, Yakushiji, Shimotsuke-city, Tochigi prefecture
0285587358
r0752tm@jichi.ac.jp
Jichimedical University
none
Other
JIchi Medical University
3311-1, Yakushiji, Shimotsuke-city, Tochigi prefecture
0285588933
rinri@jichi.ac.jp
NO
2019 | Year | 06 | Month | 01 | Day |
https://pubmed.ncbi.nlm.nih.gov/32996696/
Unpublished
https://pubmed.ncbi.nlm.nih.gov/32996696/
162
The multivariable Cox proportional hazards regression analysis showed that age over than 65: HR 1.69, 95 percent CI 1.07 to 2.81, p equal 0.025, performance status of 3 to 4: HR 1.98, 95 percent CI 1.21 to 3.23, p equal 0.008, cumulative dose of prednisolone over than 1,500mg : HR 2.21, 95 percent CI 1.37 to 3.81, p lower than 0.001, and oral cyclophosphamide: HR 1.84, 95 percent CI 1.13 to 3.00, p equal 0.016 were independent risk factors for immunosuppressant discontinuation.
2021 | Year | 11 | Month | 30 | Day |
162 patients who diagnosed with ANCA associate vasculitis from 2005 to 2016 in our institution
50 patients who were treated with immunosuppressant for initial remission induction
none (this is retrospective study)
Discontinuation of immunosuppressant due to adverse event was evaluated.
Completed
2019 | Year | 05 | Month | 28 | Day |
2019 | Year | 09 | Month | 26 | Day |
2019 | Year | 05 | Month | 28 | Day |
2020 | Year | 06 | Month | 09 | Day |
2020 | Year | 06 | Month | 09 | Day |
2020 | Year | 06 | Month | 09 | Day |
2020 | Year | 06 | Month | 09 | Day |
We analyze the clinical informations including clinical features, for example relapse, organ involvement, adverse event, discontinuing of immunosuppressant, and survival rate, retrospectively, about patients with ANCA associated vasculitis attending our devision.
2019 | Year | 05 | Month | 28 | Day |
2021 | Year | 11 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042015
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |